Pharmaceutical Leaders Question Bold Claims Regarding AI Drug Discovery

Chief executives at prominent drugmakers are casting doubt on assertions that artificial intelligence will rapidly solve major medical conditions. Industry leaders note that extensive AI screening of compound libraries has yet to produce a market-approved medication. Pharmaceutical firms continue using AI tools primarily to assist researchers in selecting biological targets and recruiting clinical trial candidates.